Lin BioScience, Inc.

Lin BioScience, Inc.verified

6696.TWO

Price:

$413

Market Cap:

$34.17B

Lin BioScience, Inc., a drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases. Its product pipeline includes LBS-008, an oral therapy for dry age-related macular degeneration (Dry AMD)and stargardt diseases (STGD1), which is under Phase 3 clinical trial to evaluate safety and efficacy in adolescent STGD1 and under phase 2 or phase 3 clinical trial to evaluate safety and efficacy in Dry AMD; LBS-007, a natural non-ATP CDC7 inhibitor for the treatment of cancers; LBS-002, an anti-tubulin to treat primary and metastatic brain tumors; and LBS-009, an oral therapy for the treatment of non-alcoholic fatty liver disease and type 2 diabetes. The company is ...[Read more]

Industry

Biotechnology

IPO Date

2018-10-08

Stock Exchange

TWO

Ticker

6696.TWO

The Current Ratio as of December 2025 (TTM) for Lin BioScience, Inc. (6696.TWO) is 41.18

According to Lin BioScience, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 41.18. This represents a change of 23.60% compared to the average of 33.32 of the last 4 quarters.

Lin BioScience, Inc. (6696.TWO) Historical Current Ratio (quarterly & annually)

How has 6696.TWO Current Ratio performed in the past?

The mean historical Current Ratio of Lin BioScience, Inc. over the last ten years is 14.45. The current 41.18 Current Ratio has changed 28.39% with respect to the historical average. Over the past ten years (40 quarters), 6696.TWO's Current Ratio was at its highest in in the June 2025 quarter at 41.18. The Current Ratio was at its lowest in in the June 2022 quarter at 0.

Quarterly (TTM)
Annual

Average

14.45

Median

12.28

Minimum

1.29

Maximum

34.45

Lin BioScience, Inc. (6696.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Lin BioScience, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.10%

Maximum Annual Current Ratio = 34.45

Minimum Annual Increase = -51.83%

Minimum Annual Current Ratio = 1.29

Quarterly (TTM)
Annual
YearCurrent RatioChange
202434.4539.55%
202324.6917.91%
202220.941.10%
20211.74-51.83%
20203.62181.38%

Lin BioScience, Inc. (6696.TWO) Average Current Ratio

How has 6696.TWO Current Ratio performed in the past?

The current Current Ratio of Lin BioScience, Inc. (6696.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

26.69

5-year avg

17.09

10-year avg

14.45

Lin BioScience, Inc. (6696.TWO) Current Ratio vs. Peers

How is 6696.TWO’s Current Ratio compared to its peers?

Lin BioScience, Inc.’s Current Ratio is greater than EirGenix Inc. (6.86), greater than Polaris Group (2.38), greater than Pell Bio-Med Technology Co., Ltd. (2.51), less than Caliway Biopharmaceuticals Co., Ltd. (118.02), greater than Sunmax Biotechnology Co., Ltd. (1.50), greater than Oneness Biotech Co., Ltd. (36.62), greater than TaiMed Biologics Inc. (24.39), greater than Center Laboratories, Inc. (0.47), greater than Tanvex BioPharma, Inc. (2.17), less than AP Biosciences Inc (49.57),

Build a custom stock screener for Lin BioScience, Inc. (6696.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lin BioScience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lin BioScience, Inc. (6696.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lin BioScience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Lin BioScience, Inc.'s Current Ratio?

How is the Current Ratio calculated for Lin BioScience, Inc. (6696.TWO)?

What is the highest Current Ratio for Lin BioScience, Inc. (6696.TWO)?

What is the 3-year average Current Ratio for Lin BioScience, Inc. (6696.TWO)?

What is the 5-year average Current Ratio for Lin BioScience, Inc. (6696.TWO)?

How does the current Current Ratio for Lin BioScience, Inc. (6696.TWO) compare to its historical average?